[Evaluation of the renal function in patients with ovarian carcinoma subjected to polychemotherapy including cisplatin or carboplatin].
Gadducci
A
A
Facchini
V
V
Dell'Arciprete
T
T
Del Bravo
B
B
Galigani
P
P
Palla
R
R
Fioretti
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology
D009944:Organoplatinum Compounds; D004317:Doxorubicin; D016190:Carboplatin; D002945:Cisplatin
Valutazione della funzione renale in pazienti con carcinoma ovarico sottoposte a polichemioterapia comprendente cisplatino o carboplatino.